Toshiaki Saeki

4.3k total citations
170 papers, 3.1k citations indexed

About

Toshiaki Saeki is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshiaki Saeki has authored 170 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 45 papers in Cancer Research and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshiaki Saeki's work include Cancer Treatment and Pharmacology (53 papers), Breast Cancer Treatment Studies (36 papers) and HER2/EGFR in Cancer Research (36 papers). Toshiaki Saeki is often cited by papers focused on Cancer Treatment and Pharmacology (53 papers), Breast Cancer Treatment Studies (36 papers) and HER2/EGFR in Cancer Research (36 papers). Toshiaki Saeki collaborates with scholars based in Japan, United States and United Kingdom. Toshiaki Saeki's co-authors include Fortunato Ciardiello, David S. Salomon, Shigemitsu Takashima, Akihiko Osaki, Takashi Shigekawa, Kurt Stromberg, Nicola Normanno, Hideki Takeuchi, Shigeto Ueda and M. Graziella Persico and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Toshiaki Saeki

161 papers receiving 3.1k citations

Peers

Countries citing papers authored by Toshiaki Saeki

Since Specialization

Citations

This map shows the geographic impact of Toshiaki Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Saeki more than expected).

Fields of papers citing papers by Toshiaki Saeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Saeki. The network helps show where Toshiaki Saeki may publish in the future.

Co-authorship network of co-authors of Toshiaki Saeki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Saeki. A scholar is included among the top collaborators of Toshiaki Saeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Saeki. Toshiaki Saeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase 2023 ·Advances in Therapy ·Naoki Inui, Yukihiro Toi, Yasuto Yoneshima, Masahiro Morise, Akito Hata, Kaoru Kubota, Toshiaki Saeki, Tomohide Tamura	5
2	Significance of the comprehensive geriatric assessment in the administration of chemotherapy to older adults with cancer: Recommendations by the Japanese Geriatric Oncology Guideline Committee 2023 ·Journal of Geriatric Oncology ·Kiichiro Ninomiya, Daisuke Inoue, Ken Sugimoto, Chie Tanaka, Keiko Nemoto Murofushi, Toru Okuyama, (unknown), Chiyo K. Imamura, Daisuke Sakai, Naomi Sakurai, (unknown), Kazuo Tamura, Toshiaki Saeki, Hiroshi Ishiguro	8
3	Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03) 2023 ·Breast Cancer Research and Treatment ·Kokoro Kobayashi, Norikazu Masuda, Toshiro Mizuno, (unknown), Yutaka Tokuda, Tetsuhiro Yoshinami, Hidetoshi Kawaguchi, Shoichiro Ohtani, Toshiaki Saeki, Masakazu Toi, Masahiro Takeuchi, Yoshinori Ito	0
4	Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents’ attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons 2022 ·Supportive Care in Cancer ·Nobu Akiyama, Takuho Okamura, Minoru Yoshida, Shun‐ichi Kimura, Shingo Yano, Isao Yoshida, Hitoshi Kusaba, Kosuke Takahashi, Hiroyuki Fujita, Keitaro Fukushima, Hiromichi Iwasaki, Kazuo Tamura, Toshiaki Saeki, Yasushi Takamatsu, Sadamoto Zenda	1
5	Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer 2017 ·In Vivo ·Junichiro Watanabe, Yoshinori Ito, Toshiaki Saeki, Norikazu Masuda, Toshimi Takano, Shintaro Takao, Kazuhiko Nakagami, Koichiro Tsugawa, (unknown), (unknown), Takahiro Nakayama	18
6	A global phase III clinical study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients 2017 ·Annals of Oncology ·Toshiaki Saeki, Hirofumi Mukai, Jungsil Ro, (unknown), Yasuhiro Fujiwara, Shigenori E. Nagai, (unknown), Junichiro Watanabe, Shoichiro Ohtani, S.B. Kim, Katsumasa Kuroi, Koichiro Tsugawa, Yutaka Tokuda, Hiroji Iwata, Y.H. Park, Youngsen Yang, Yoshihiro Nambu	7
7	Phase I study of weekly nab‐paclitaxel combined with S‐1 in patients with human epidermal growth factor receptor type 2‐negative metastatic breast cancer 2015 ·Cancer Science ·Junji Tsurutani, Katsumasa Kuroi, Tsutomu Iwasa, Masaki Miyazaki, Shinichi Nishina, (unknown), Junko Tanizaki, Kunio Okamoto, Toshinari Yamashita, Tomoyuki Aruga, Takashi Shigekawa, Yoshifumi Komoike, Toshiaki Saeki, Kazuhiko Nakagawa	9
8	[Successful treatment of trastuzumab-resistant HER2-positive breast cancer with extensive liver metastases using the combination of trastuzumab and capecitabine - a case report]. 2013 ·PubMed ·Takashi Shigekawa, Hideki Takeuchi, (unknown), (unknown), Michiko Sugiyama, (unknown), (unknown), Akihiko Osaki, Toshiaki Saeki	3
9	Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy 2012 ·The American Journal of Surgery ·Takashi Shigekawa, (unknown), Hideki Takeuchi, (unknown), (unknown), Michiko Sugiyama, Hiroshi Sano, Kazuo Matsuura, Takao Takahashi, (unknown), Akihiko Osaki, Toshiaki Saeki	15
10	The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype 2010 ·Cancer Chemotherapy and Pharmacology ·Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, M. Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima	9
11	Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice 2009 ·Cancer Science ·Hironobu Minami, Kenji Kawada, Yasutsuna Sasaki, Makoto Tahara, Tadahiko Igarashi, Kuniaki Itoh, Hirofumi Fujii, Toshiaki Saeki, Kazuhiro Ozawa, Hitoshi Sato	33
12	Adenoid basal carcinoma of the uterine cervix: Report of two cases with reference to adenosquamous carcinoma 2005 ·Pathology International ·Norihiro Teramoto, Rieko Nishimura, Toshiaki Saeki, (unknown), Masamichi Hiura	15
13	Section 5. Breast 2002 ·Biomedicine & Pharmacotherapy ·Shozo Ohsumi, Shigemitsu Takashima, Toshiaki Saeki, Kenjiro Aogi	2
14	[Chemotherapy for peritoneal dissemination in gastric cancer under ureteral catheterization]. 1996 ·PubMed ·Yuko Kubo, Akira Kurita, Toshiaki Saeki, (unknown), Minoru Tanada, Wataru Takiyama, Hiroshi Saeki, S Takashima	1
15	Two Resected Cases of Gastric Cancer Arizing from the Gastric Tube Following Esophageal Cancer Surgery. 1996 ·The Japanese Journal of Gastroenterological Surgery ·(unknown), Wataru Takiyama, Toshiaki Saeki, Shigemitsu Takashima, (unknown)	4
16	Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas 1994 ·British Journal of Cancer ·(unknown), (unknown), Nicola Normanno, G Merlo, GR Johnson, WJ Gullick, Fortunato Ciardiello, Toshiaki Saeki, Ralf Brandt, (unknown)	105
17	Expression of transforming growth factor alpha (TGFα) in breast cancer 1991 ·Annals of Oncology ·Fortunato Ciardiello, (unknown), M L McGeady, Daniel S. Liscia, Toshiaki Saeki, Caterina Bianco, David S. Salomon	45
18	Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. 1990 ·PubMed ·Fortunato Ciardiello, M L McGeady, (unknown), Fulvio Basolo, Nancy E. Hynes, Beatrice Langton-Webster, Hiroshi Yokozaki, Toshiaki Saeki, James Elliott, Hideo Masui	89
19	The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein 1989 ·Surgery Today ·Masahiko Nishiyama, (unknown), (unknown), Ryungsa Kim, Toshiaki Saeki, (unknown), (unknown), (unknown), Tetsuya Toge, Minoru Niimoto, Takao Hattori	1
20	Clinical study on resectable gastric cancer with serosal invasion. 1988 ·The Japanese Journal of Gastroenterological Surgery ·Toshiaki Saeki, Takashi Tanaka, Masahiko Nishiyama, (unknown), (unknown), (unknown), (unknown), Minoru Niimoto, Takao Hattori	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact